ORIX Corporation
IX | NYSE
$39.66
+$0.36 (+0.92%)
Sep 21, 2026, 11:15 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 30, 2026 | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 3.53T | 2.87T | 2.81T | 2.66T | 2.51T | 2.29T |
Cost of Revenue | 2.4T | 1.67T | 1.64T | 1.62T | 1.57T | 1.48T |
Gross Profit | 1.13T | 1.2T | 1.17T | 1.04T | 940.79B | 812.44B |
Operating Income | 770.68B | 331.83B | 360.71B | 335.92B | 292.88B | 258.81B |
Interest Income | 387.62B | n/a | 348B | 319.48B | 281.7B | 271.19B |
Pretax Income | 733.13B | 480.46B | 469.98B | 392.18B | 509.45B | 287.56B |
Net Income | 475.04B | 351.63B | 346.13B | 290.34B | 317.38B | 192.38B |
Selling & General & Admin | n/a | 646.05B | 627.63B | 555.97B | 522.78B | 456.8B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 361.57B | 222.67B | 185.7B | 148.62B | 125.12B | 96.83B |
Operating Expenses | 361.57B | 868.72B | 813.33B | 704.59B | 647.9B | 553.62B |
Interest Expense | 205.58B | 169.05B | 188.33B | 127.62B | 68.23B | 78.07B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.76T | 2.54T | 2.45T | 2.33T | 2.22T | 2.03T |
Income Tax Expense | 247.16B | 128.83B | 131.39B | 95.25B | 186.59B | 90.75B |
Shares Outstanding (Basic) | 1.12B | 1.14B | 1.16B | 1.18B | 1.2B | 1.24B |
Shares Outstanding (Diluted) | 1.12B | 1.14B | 1.16B | 1.18B | 1.2B | 1.24B |
EPS (Basic) | 425.01 | 307.74 | 298.55 | 231.35 | 259.37 | 155.54 |
EPS (Diluted) | 423.42 | 307.16 | 298.05 | 231.04 | 259.07 | 155.39 |
EBITDA | 1.37T | 944.67B | 916.36B | 813.04B | 743.78B | 655.33B |
EBIT | 938.71B | 545.14B | 552.11B | 472.79B | 423.44B | 339.38B |
Depreciation & Amortization | 429.2B | 399.53B | 364.24B | 340.25B | 320.34B | 315.96B |
Add to Watchlist
Select watchlists to add or remove IX